Seres Therapeutics (MCRB) Misses Q3 EPS by 25c
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.33), $0.25 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of ($0.33), $0.25 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.